Sunday, June 14, 2026 Evidence-led medical research news
The First Cohort
Medical research, with the receipts

fda

9 stories tagged "fda"

Drugs & FDA

Europe had this sunscreen in 1999. The FDA approved it Tuesday.

A new chemical UV filter Europe approved in 1999 just cleared the FDA after a 21-year wait, while Americans relied on ingredients the agency's own 2019 review could not call safe.

Drugs & FDA

The Macaques Get a Reprieve. Pharma Gets a Faster Pipeline.

The FDA's new draft guidance lets oncology developers cut animal studies for certain biologics and conjugated products. The replacement laboratory methods are still being validated.

Cancer

Pancreatic cancer's undruggable wall just cracked. The follow-up is 8.5 months and the money was already placed.

Revolution Medicines' daraxonrasib nearly doubled median overall survival versus chemotherapy in previously treated metastatic pancreatic cancer at ASCO 2026, with 8.5 months of follow-up and a two-billion-dollar Royalty Pharma deal already riding on what comes next.

Drugs & FDA

Another Clot Problem at Abiomed: The FDA Flags an Impella Introducer, and the Pattern Keeps Growing

FDA flags Abiomed's 14Fr Low Profile Introducer Kit after a higher than expected complaint rate of clots forming on the device during prolonged Impella CP support. Three serious injuries reported, no deaths. The pattern keeps growing.

Drugs & FDA

The FDA Approved a Better Penile Implant. For Most Men, ED Is the Heart Warning Them First.

The FDA approved Coloplast's Titan Prime inflatable penile prosthesis on June 3, 2026. For the men whose vasculature is past saving, it is a meaningful device upgrade. For most men with new ED, the more useful conversation is what the small arteries are failing to do years before the coronaries noti

Drugs & FDA

Andrew Huberman's peptide masterclass and the published evidence

Andrew Huberman's June 1 episode on peptides walks through BPC-157 and seven other compounds. The published human evidence for its lead substance runs to fewer than thirty people.

Drugs & FDA

FDA's New Gene Therapy Shortcut Leans on 'Platform Knowledge.' Six Months Ago, They Revoked Sarepta's After Three Patient Deaths.

FDA's new gene therapy draft guidance invites sponsors to lean on "platform knowledge" to streamline submissions, six months after the agency revoked Sarepta's AAVrh74 platform designation following three patient deaths.

Infectious Disease

Xocova clears the FDA. What it actually prevents is the smaller story.

The FDA approved Shionogi's ensitrelvir for post-exposure COVID prevention, citing a 67% relative risk reduction. Look at what the trial actually measured and a different story comes into focus.

Drugs & FDA

Hepatitis Delta Has Waited Forty-Nine Years for a Drug. The FDA Made American Patients Wait Three Extra.

The FDA cleared bulevirtide for chronic hepatitis delta this week, six years after Europe started using it and three years after a U.S. application was turned down on manufacturing grounds. The wait is its own story.